U.S., Feb. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07427992) titled 'Real-WorlD ZolbetUximab in Patients With HER-2 Negative and CLaudin 18.2 PosItive MetastatiC AdEnocarcinoma' on Feb. 17.
Brief Summary: The primary objective is to validate, throughout a national real-world study, the efficacy and safety of Zolbetuximab combined with FOLFOX or XELOX regimens. Specific clinical issues will be studied by pre-planned subgroup analyses, addressing practical clinical needs which have not been specifically investigated in randomized clinical trials.
Study Start Date: June 20, 2025
Study Type: OBSERVATIONAL
Condition:
Gastric Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Recruitment Status: ...